IAPP and Alzheimer disease: The study links bacterial endotoxin LPS to amyloid diseases like T2D and AD by speeding up peptide fibrillization. CQDs counteract this by inhibiting Aβ and IAPP, indicating potential as anti-amyloidosis nanomedicine.